Our primary results suggested that SERS could be a meaningful technique for prediction of early biochemical recurrence in prostate cancer.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: